A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

NCT06696755 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

195

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar I Disorder
Bipolar II Disorder

Interventions

DRUG: Icalcaprant
DRUG: Placebo for Icalcaprant

Sponsor

AbbVie